Outcomes of minimally invasive surgery for pulmonary metastasis: who benefits the most?
- PMID: 38973795
- PMCID: PMC11223553
- DOI: 10.5114/wiitm.2024.140300
Outcomes of minimally invasive surgery for pulmonary metastasis: who benefits the most?
Abstract
Introduction: Metastatic disease is one of the main causes of death and factors affecting overall survival. It is known that selected patients with pulmonary oligometastases whose primary tumor is under control and who have adequate respiratory capacity may benefit from metastasectomy by resecting all detected lesions.
Aim: To report our findings on the use of video-assisted thoracoscopic surgery (VATS) for pulmonary metastasectomy, with a focus on identifying suitable candidates.
Material and methods: Between August 2010 and 2023 a total of 532 pulmonary metastasectomy procedures were performed in our institution. Metastasectomy was performed with VATS for 281 of those patients.
Results: VATS metastasectomy was performed in 131 patients with a single lesion on preoperative imaging, while 110 patients underwent metastasectomy for multiple lesions. The rate was significantly (p < 0.05) lower in the group with multiple lesions removed during surgery (38 months) than in the group with only one lesion removed during surgery (60 months). The predicted survival time in the group with other tumor histology (79 months) was significantly (p < 0.05) higher than in the groups with tumor histology carcinoma (41.4 months) and sarcoma (55.5 months).
Conclusions: The best prognosis after metastasectomy is provided in cases with a single nodule. Grade is also an important prognostic factor affecting survival, particularly for grade 1 tumor. The histopathological type of the primary tumor is also a significant prognostic factor affecting survival after pulmonary metastasectomy in secondary pulmonary neoplasms, particularly for sarcoma and carcinoma.
Keywords: minimally invasive thoracic surgery; pulmonary metastasectomy; video-assisted thoracic surgery.
Copyright: © 2024 Fundacja Videochirurgii.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







Similar articles
-
Survival and Local Recurrence After Video-Assisted Thoracoscopic Lung Metastasectomy.World J Surg. 2016 Feb;40(2):373-9. doi: 10.1007/s00268-015-3254-7. World J Surg. 2016. PMID: 26464153
-
Prognosis of video-assisted thoracoscopic pulmonary metastasectomy in patients with colorectal cancer lung metastases: an analysis of 154 cases.Int J Colorectal Dis. 2017 Jun;32(6):897-905. doi: 10.1007/s00384-017-2768-x. Epub 2017 Feb 7. Int J Colorectal Dis. 2017. PMID: 28176005
-
Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.World J Surg Oncol. 2021 Jan 30;19(1):33. doi: 10.1186/s12957-021-02138-0. World J Surg Oncol. 2021. PMID: 33516218 Free PMC article.
-
Video-assisted thoracoscopic surgery versus open thoracotomy in pulmonary metastasectomy: a meta-analysis of observational studies.Interact Cardiovasc Thorac Surg. 2016 Feb;22(2):200-6. doi: 10.1093/icvts/ivv309. Epub 2015 Nov 20. Interact Cardiovasc Thorac Surg. 2016. PMID: 26590306 Review.
-
Thoracoscopic Management of Pulmonary Metastases.Thorac Surg Clin. 2016 Feb;26(1):91-7. doi: 10.1016/j.thorsurg.2015.09.011. Thorac Surg Clin. 2016. PMID: 26611514 Review.
References
-
- Downey RJ. Surgical treatment of pulmonary metastases. Surg Oncol Clin N Am 1999; 8: 341. - PubMed
-
- Treasure T. Pulmonary metastasectomy for colorectal cancer: weak evidence and no randomised trials. Eur J Cardiothorac Surg 2008; 33: 300-2. - PubMed
-
- Molnar TF, Gebitekin C, Turna A. What are the considerations in the surgical approach in pulmonary metastasectomy? J Thorac Oncol 2010; 5 (6 Suppl 2): S140-4. - PubMed
LinkOut - more resources
Full Text Sources